Search research articles
Contact Us
Filters
Showing results (111-120 of 308) with videos related to
Page
of 31
Sort By:
The Laryngoscope
|
October 12, 2022
Phytomedicine ELOM-080 in Acute Viral Rhinosinusitis: A Randomized, Placebo-Controlled, Blinded Clinical Trial
Oliver Pfaar, Achim G Beule, Detmar Jobst, et al.
The Journal of Allergy and Clinical Immunology. Global
|
November 18, 2024
A RESPONSE to anti<b>-</b>IL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol
Petros Bakakos, Isam Alobid, Jannis Constantinidis, et al.
Allergy
|
July 27, 2021
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R Durham, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 18, 2018
Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy
Carmen Vidal, Pablo Rodríguez Del Río, Francisco Gude, et al.
Journal of Personalized Medicine
|
May 27, 2023
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
Umit M Sahiner, Mattia Giovannini, Maria M Escribese, et al.
Clinical and Translational Allergy
|
September 22, 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA<sup>2</sup>LEN study
Georg Boelke, Uwe Berger, Karl-Christian Bergmann, et al.
Allergy
|
November 4, 2024
The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial
Monika Gappa, Rémi Gagnon, Fritz Horak, et al.
The Lancet Regional Health. Europe
|
December 16, 2024
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial
Antje Schuster, Davide Caimmi, Hendrik Nolte, et al.
Advances in Therapy
|
June 12, 2026
Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review and Network Meta-analysis
Joseph K Han, Joaquim Mullol, Claire Hopkins, et al.
Allergy
|
March 31, 2025
Meta-Analysis of PQ Grass 27600 SU Efficacy and Quality of Life From Phase III Trials
Stefan Zielen, Jonathan A Bernstein, Oliver Pfaar, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 308) with videos related to
Sort By:
Page
of 31
The Laryngoscope
|
October 12, 2022
Phytomedicine ELOM-080 in Acute Viral Rhinosinusitis: A Randomized, Placebo-Controlled, Blinded Clinical Trial
Oliver Pfaar, Achim G Beule, Detmar Jobst, et al.
The Journal of Allergy and Clinical Immunology. Global
|
November 18, 2024
A RESPONSE to anti<b>-</b>IL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol
Petros Bakakos, Isam Alobid, Jannis Constantinidis, et al.
Allergy
|
July 27, 2021
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R Durham, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 18, 2018
Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy
Carmen Vidal, Pablo Rodríguez Del Río, Francisco Gude, et al.
Journal of Personalized Medicine
|
May 27, 2023
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
Umit M Sahiner, Mattia Giovannini, Maria M Escribese, et al.
Clinical and Translational Allergy
|
September 22, 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA<sup>2</sup>LEN study
Georg Boelke, Uwe Berger, Karl-Christian Bergmann, et al.
Allergy
|
November 4, 2024
The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial
Monika Gappa, Rémi Gagnon, Fritz Horak, et al.
The Lancet Regional Health. Europe
|
December 16, 2024
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial
Antje Schuster, Davide Caimmi, Hendrik Nolte, et al.
Advances in Therapy
|
June 12, 2026
Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review and Network Meta-analysis
Joseph K Han, Joaquim Mullol, Claire Hopkins, et al.
Allergy
|
March 31, 2025
Meta-Analysis of PQ Grass 27600 SU Efficacy and Quality of Life From Phase III Trials
Stefan Zielen, Jonathan A Bernstein, Oliver Pfaar, et al.
Page
of 31